home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

FDA’s Regulation of Unique Device Identification (UDI) - Are you Prepared?

 
  November 08, 2012  
     
 
ComplianceOnline, Online Event
2012-12-05


Why Should You Attend:

In July 2012, the FDA issued the draft regulations for Unique Device Identification (UDI). This draft regulation describes new requirements of labeling medical devices as well as providing information to a new database that FDA maintains.

This webinar explores the explicit requirements as well as the hidden requirements in the draft UDI regulation.

Your Quality Management System (QMS) should be able to address these questions quickly and easily. If not, then your team needs to attend this webinar!

  • Do you know what needs to be on a label today and how the draft UDI regulation will change the label?
  • If you ship a device in packages of 1, 5, 10, and 25, will you be able to mark each package with only one UDI?
  • Do you know who will issue the unique code for your device? If you think it is FDA, you may be surprised!
  • Can you state the fixed and variable elements that need to be on your device label?
  • Do you know the correct format for a date?
  • Is it true or false that FDA will require you to use only 2D barcodes?
  • Can you put the marking on the label only? Does it have to be on the device?
  • What is the responsibility for the designated person to inform the FDA of each code?
  • Will you need a GMDN code for your device? What is a GMDN code?

Areas Covered in the Webinar:

  • An explanation of the draft regulation.
    • When a UDI is required
    • What is on a label
    • What is in the new FDA database
  • A description of the changes to the device regulations
    • New Part 830 on Unique Device Identification
    • Part 801 on Labeling
    • Part 803 on Medical Device Reports
    • Part 806 on Corrections and Removals
    • Part 807 on Registration and Listing
    • Part 820 on the Quality Management System
    • Part 821 on Device Tracking
  • An analysis of the “hidden” requirements
    • Will a new UDI require a design change
    • When will a new UDI trigger a new 510(k) and vice versa
    • When does an update to the DMR require a new UDI
  • Implementation Recommendations
    • Integrating requirements
    • Many small changes touch the whole system
  • Inspections
    • What can we expect FDA Inspectors to look for
    • How could Inspectors compare UDI, device listing, MDRs, and recalls
    • Will FDA have the potential for data mining before the inspection

Who will Benefit:

This webinar is for people involved in understanding, analyzing, and implementing the UDI regulations.

People in the following roles can especially benefit from the knowledge in this webinar:

  • Quality Managers
  • Quality Professionals
  • Production Managers
  • Production Supervisors
  • Manufacturing Engineers
  • Production Engineers
 
 
Organized by: Complianceonline
Invited Speakers: Dan, is the President of Ombu Enterprises, LLC, a company offering training and execution in Operational Excellence, focused on analytic skills and a systems approach to operations management. Dan has more than 30 years experience in quality, operations, and program management in regulated industries including aviation, defense, medical devices, and clinical labs. He has a Masters Degree in Mathematics; is an ASQ certified Biomedical Auditor, Quality Auditor, Quality Engineer, Reliability Engineer, and Six Sigma Black Belt; and is certified by APICS in Resource Management.
 
Deadline for Abstracts: 2012-11-04
 
Registration:

 
E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.